Saw palmetto did not differ from placebo for benign prostatic hyperplasia in men

Your saved search

Your RSS Feed

Comment

. 2006 Jul-Aug;145(1):12.

Affiliations

Comment

Timothy J Wilt. ACP J Club. 2006 Jul-Aug.

. 2006 Jul-Aug;145(1):12.

¹ Minneapolis VA Center for Chronic Disease Outcomes Research, Minneapolis, Minnesota, USA.

No abstract available

Comment on

Saw palmetto for benign prostatic hyperplasia.
Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL. Bent S, et al. N Engl J Med. 2006 Feb 9;354(6):557-66. doi: 10.1056/NEJMoa053085. N Engl J Med. 2006. PMID: 16467543 Clinical Trial.

Plant extracts: sense or nonsense?
Madersbacher S, Berger I, Ponholzer A, Marszalek M. Madersbacher S, et al. Curr Opin Urol. 2008 Jan;18(1):16-20. doi: 10.1097/MOU.0b013e3282f0d5c8. Curr Opin Urol. 2008. PMID: 18090484 Review.
Saw palmetto for benign prostatic hyperplasia: just how effective is it?
Roehrborn CG. Roehrborn CG. Nat Clin Pract Urol. 2006 Aug;3(8):420-1. doi: 10.1038/ncpuro0553. Nat Clin Pract Urol. 2006. PMID: 16902517 No abstract available.
Saw palmetto ineffective for benign prostatic hyperplasia.
[No authors listed] [No authors listed] J Fam Pract. 2006 May;55(5):378. J Fam Pract. 2006. PMID: 16722007 No abstract available.
Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.
McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS. McVary KT, et al. J Urol. 2007 Apr;177(4):1401-7. doi: 10.1016/j.juro.2006.11.037. J Urol. 2007. PMID: 17382741 Clinical Trial.
Diagnosis and management of benign prostatic hyperplasia.
Edwards JL. Edwards JL. Am Fam Physician. 2008 May 15;77(10):1403-10. Am Fam Physician. 2008. PMID: 18533373 Review.